EQUIBREM Trademark

Trademark Overview

On Thursday, June 27, 2019, a trademark application was filed for EQUIBREM with the United States Patent and Trademark Office. The USPTO has given the EQUIBREM trademark a serial number of 88491673. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, January 24, 2022. This trademark is owned by Arena Pharmaceuticals, Inc.. The EQUIBREM trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for human use to treat ulcerative colitis, diseases and disorders of the gastrointestinal tract, Crohn's disease, irritable bowel syndrome, autoimmune diseases and dermatological diseases and disorders
equibrem

General Information

Serial Number88491673
Word MarkEQUIBREM
Filing DateThursday, June 27, 2019
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, January 24, 2022
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, April 28, 2020

Trademark Statements

Goods and ServicesPharmaceutical preparations for human use to treat ulcerative colitis, diseases and disorders of the gastrointestinal tract, Crohn's disease, irritable bowel syndrome, autoimmune diseases and dermatological diseases and disorders

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, July 8, 2019
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameArena Pharmaceuticals, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSan Diego, CA 92121
Party NameArena Pharmaceuticals, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSan Diego, CA 92121

Trademark Events

Event DateEvent Description
Monday, January 24, 2022ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, January 24, 2022ABANDONMENT - NO USE STATEMENT FILED
Wednesday, May 26, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, May 24, 2021SOU EXTENSION 2 GRANTED
Monday, May 24, 2021SOU EXTENSION 2 FILED
Monday, May 24, 2021TEAS EXTENSION RECEIVED
Wednesday, December 16, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, December 14, 2020SOU EXTENSION 1 GRANTED
Monday, December 14, 2020SOU EXTENSION 1 FILED
Monday, December 14, 2020TEAS EXTENSION RECEIVED
Tuesday, June 23, 2020NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, April 28, 2020OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, April 28, 2020PUBLISHED FOR OPPOSITION
Wednesday, April 8, 2020NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, March 24, 2020APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, March 19, 2020EXAMINER'S AMENDMENT ENTERED
Thursday, March 19, 2020NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Thursday, March 19, 2020EXAMINERS AMENDMENT E-MAILED
Thursday, March 19, 2020EXAMINERS AMENDMENT -WRITTEN
Thursday, September 19, 2019NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, September 19, 2019NON-FINAL ACTION E-MAILED
Thursday, September 19, 2019NON-FINAL ACTION WRITTEN
Wednesday, September 18, 2019ASSIGNED TO EXAMINER
Tuesday, August 13, 2019PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED
Thursday, August 8, 2019ASSIGNED TO LIE
Thursday, August 1, 2019TEAS VOLUNTARY AMENDMENT RECEIVED
Monday, July 8, 2019NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Monday, July 1, 2019NEW APPLICATION ENTERED IN TRAM

Related Keywords

equibrem diseases disorders disease irritable bowel dermatological autoimmune syndrome crohn gastrointestinal